Outcome of Patients With Recurrent Hepatocellular Carcinoma in Liver Transplantation

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2121-2122

  Park, J W ^a   Lee, K W ^a   Kim, S J ^a   Choi, S H ^a   Heo, J S ^a   Kwon, C H D ^a   Kim, D J ^a   Han, Y S ^a   Lee, S K ^a   Joh, J W ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; STEROID;

ADRENAL GLAND; ADULT; AGED; ARTICLE; BONE; BRAIN; CANCER LOCALIZATION; CANCER STAGING; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; DRUG PULSE THERAPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT; LIVER TRANSPLANTATION; LUNG; LYMPH NODE; MALE; MILAN CRITERIA; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; RISK FACTOR; SKIN; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM STAGING; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33846051423     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.030     Document Type: Article

References (5)

1. Shetty K., Timmins K., Brensinger C., et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 10 (2004) 911
2. Guzman G., Alagiozian-Angelova V., Layden-Almer J.E., et al. p53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplantation patients. Mod Pathol 18 (2005) 1498
3. Zhou Q., He Q., and Liang L.J. Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance. World J Gastroenterol 9 (2003) 2450
4. Zhang Y.J., Chen S.Y., Chen C.J., et al. Polymorphism in cyclin D1 gene and hepatocellular carcinoma. Mol Carcinog 33 (2002) 125
5. Vivarelli M., Cucchetti A., Piscaglia F., et al. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: Key role of immunosuppression. Liver Transpl 11 (2005) 497